873055-92-6 Usage
Uses
Used in Pharmaceutical Research and Development:
(3-Amino-4-tert-butylphenyl)carbamic acid tert-butyl ester is used as a research compound for the development and testing of pharmaceutical compounds. It serves as a key intermediate in the synthesis of potential drug candidates for various medical conditions, contributing to the advancement of new therapeutic agents.
Used in Laboratory Settings:
In laboratory settings, (3-Amino-4-tert-butylphenyl)carbamic acid tert-butyl ester is used as a reagent in chemical reactions and experiments. Its unique structure and properties make it a valuable tool for understanding the mechanisms of drug action and the development of novel therapeutic approaches.
Used in Drug Synthesis:
(3-Amino-4-tert-butylphenyl)carbamic acid tert-butyl ester is used as a building block in the synthesis of complex organic molecules, particularly in the pharmaceutical industry. Its versatile chemical properties allow for the creation of a wide range of drug candidates with potential therapeutic applications.
Used in Safety and Protocol Development:
Due to its potential health hazards, (3-Amino-4-tert-butylphenyl)carbamic acid tert-butyl ester is also used in the development of safety protocols and handling procedures. Understanding the risks associated with this chemical compound is essential for ensuring the safety of researchers and laboratory personnel during its use in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 873055-92-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,0,5 and 5 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 873055-92:
(8*8)+(7*7)+(6*3)+(5*0)+(4*5)+(3*5)+(2*9)+(1*2)=186
186 % 10 = 6
So 873055-92-6 is a valid CAS Registry Number.
873055-92-6Relevant academic research and scientific papers
Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
-
Paragraph 0587, (2015/09/22)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
-
, (2012/04/23)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
